Predonine



Indications and Reactions:

Role Indications Reactions
Primary
Colitis Ulcerative 30.8%
Systemic Lupus Erythematosus 15.4%
Adrenal Insufficiency 7.7%
Antipyresis 7.7%
Depression 7.7%
Drug Eruption 7.7%
Gastrointestinal Disorder Therapy 7.7%
Polymyositis 7.7%
Staphylococcal Sepsis 7.7%
Eosinophilic Myocarditis 33.3%
Osteoarthritis 33.3%
Serotonin Syndrome 33.3%
Secondary
Rheumatoid Arthritis 32.9%
Colitis Ulcerative 9.1%
Prophylaxis 7.2%
Drug Use For Unknown Indication 5.0%
Renal Transplant 4.9%
Hypertension 4.9%
Product Used For Unknown Indication 4.7%
Asthma 4.1%
Castleman's Disease 4.0%
Chronic Hepatitis C 3.7%
Interstitial Lung Disease 2.9%
Osteoporosis 2.7%
Crohn's Disease 2.4%
Juvenile Arthritis 1.8%
Gastritis 1.8%
Diabetes Mellitus 1.7%
Infection Prophylaxis 1.7%
Pustular Psoriasis 1.6%
Idiopathic Thrombocytopenic Purpura 1.5%
Insomnia 1.4%
Vomiting 12.8%
Pneumocystis Jiroveci Pneumonia 11.3%
Sepsis 11.0%
Pneumonia 6.5%
White Blood Cell Count Decreased 5.8%
White Blood Cell Count Increased 5.5%
Renal Impairment 4.9%
Pulmonary Tuberculosis 4.5%
Rash 3.9%
Diabetes Mellitus 3.8%
Toxic Epidermal Necrolysis 3.7%
Spinal Compression Fracture 3.5%
Gastroenteritis 3.3%
Interstitial Lung Disease 3.2%
Pneumocystis Jirovecii Pneumonia 3.2%
Stomatitis 2.9%
Bronchopulmonary Aspergillosis 2.7%
Pyrexia 2.6%
Upper Respiratory Tract Inflammation 2.6%
Erythema Multiforme 2.4%
Concomitant
Rheumatoid Arthritis 29.5%
Prophylaxis 14.4%
Product Used For Unknown Indication 9.5%
Colitis Ulcerative 5.5%
Drug Use For Unknown Indication 5.5%
Hypertension 5.4%
Osteoporosis 2.9%
Idiopathic Thrombocytopenic Purpura 2.8%
Asthma 2.7%
Chronic Hepatitis C 2.6%
Behcet's Syndrome 2.6%
Insomnia 2.6%
Gastritis 2.1%
Crohn's Disease 2.0%
Acute Lymphocytic Leukaemia 1.9%
Diabetes Mellitus 1.9%
Constipation 1.7%
Multiple Myeloma 1.6%
Infection Prophylaxis 1.5%
Renal Transplant 1.4%
White Blood Cell Count Decreased 14.2%
Renal Impairment 7.5%
Pyrexia 7.5%
White Blood Cell Count Increased 7.0%
Interstitial Lung Disease 6.8%
Rash 6.2%
Vomiting 6.0%
Pneumonia 5.9%
Platelet Count Decreased 5.6%
Sepsis 5.1%
Liver Disorder 4.7%
Pneumocystis Jiroveci Pneumonia 3.5%
Hepatic Function Abnormal 3.3%
Respiratory Failure 2.9%
Thrombocytopenia 2.9%
Agranulocytosis 2.5%
Toxic Epidermal Necrolysis 2.3%
Renal Failure Acute 2.1%
Asthma 2.0%
Melaena 2.0%